中国急救医学
中國急救醫學
중국급구의학
CHINESE JOURNAL OF CRITICAL CARE MEDICINE
2010年
1期
31-34
,共4页
徐敏%黄亮%李闽云%曹春水%郭国明%季勇%黄晓军
徐敏%黃亮%李閩雲%曹春水%郭國明%季勇%黃曉軍
서민%황량%리민운%조춘수%곽국명%계용%황효군
急性肺损伤%血小板活化因子%复方丹参注射液%凝血功能
急性肺損傷%血小闆活化因子%複方丹參註射液%凝血功能
급성폐손상%혈소판활화인자%복방단삼주사액%응혈공능
Acute lung injury%Platelet -activating factor%Compound salvia mihiorrhiza parenteral solution%Blood coagulation function
目的 探讨复方丹参注射液对急性肺损伤(ALI)患者血清血小板活化因子(PAF)表达及凝血系统功能的影响.方法 ALI患者40例,随机分为对照组和治疗组,每组各20例,对照组予以治疗原发病、机械通气、激素治疗、抗感染、维持水电解质及酸碱平衡等常规治疗.治疗组在常规治疗的基础上加用复方丹参注射液20 mL溶于5%葡萄糖注射液250 mL中静脉滴注,1次/d,共3 d.分别于治疗前及治疗3 d后测定血清PAF、血栓素B_2(TXB_2)和凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、血小板参数及血气分析.比较对照组和治疗组治疗前后血清PAF、TXB_2和PT、APTT、FIB、血小板参数及血气分析变化.结果 与治疗前比较,治疗后两组氧合均改善,PAF和TXB_2下降,PT、APTT延长,FIB下降,血小板参数改善(均P<0.01).与对照组比较,治疗组治疗后氧合显著改善,PAF和TXB_2显著下降,PT、APTT显著延长,FIB显著升高,血小板参数显著改善(P<0.01或P<0.05).但两组病死率比较差异无统计学意义(P>0.05).结论 复方丹参能减少ALI患者PAF的表达,改善ALI患者高凝状态和氧合,为临床早期治疗ALI提供了新方法.
目的 探討複方丹參註射液對急性肺損傷(ALI)患者血清血小闆活化因子(PAF)錶達及凝血繫統功能的影響.方法 ALI患者40例,隨機分為對照組和治療組,每組各20例,對照組予以治療原髮病、機械通氣、激素治療、抗感染、維持水電解質及痠堿平衡等常規治療.治療組在常規治療的基礎上加用複方丹參註射液20 mL溶于5%葡萄糖註射液250 mL中靜脈滴註,1次/d,共3 d.分彆于治療前及治療3 d後測定血清PAF、血栓素B_2(TXB_2)和凝血酶原時間(PT)、活化部分凝血活酶時間(APTT)、纖維蛋白原(FIB)、血小闆參數及血氣分析.比較對照組和治療組治療前後血清PAF、TXB_2和PT、APTT、FIB、血小闆參數及血氣分析變化.結果 與治療前比較,治療後兩組氧閤均改善,PAF和TXB_2下降,PT、APTT延長,FIB下降,血小闆參數改善(均P<0.01).與對照組比較,治療組治療後氧閤顯著改善,PAF和TXB_2顯著下降,PT、APTT顯著延長,FIB顯著升高,血小闆參數顯著改善(P<0.01或P<0.05).但兩組病死率比較差異無統計學意義(P>0.05).結論 複方丹參能減少ALI患者PAF的錶達,改善ALI患者高凝狀態和氧閤,為臨床早期治療ALI提供瞭新方法.
목적 탐토복방단삼주사액대급성폐손상(ALI)환자혈청혈소판활화인자(PAF)표체급응혈계통공능적영향.방법 ALI환자40례,수궤분위대조조화치료조,매조각20례,대조조여이치료원발병、궤계통기、격소치료、항감염、유지수전해질급산감평형등상규치료.치료조재상규치료적기출상가용복방단삼주사액20 mL용우5%포도당주사액250 mL중정맥적주,1차/d,공3 d.분별우치료전급치료3 d후측정혈청PAF、혈전소B_2(TXB_2)화응혈매원시간(PT)、활화부분응혈활매시간(APTT)、섬유단백원(FIB)、혈소판삼수급혈기분석.비교대조조화치료조치료전후혈청PAF、TXB_2화PT、APTT、FIB、혈소판삼수급혈기분석변화.결과 여치료전비교,치료후량조양합균개선,PAF화TXB_2하강,PT、APTT연장,FIB하강,혈소판삼수개선(균P<0.01).여대조조비교,치료조치료후양합현저개선,PAF화TXB_2현저하강,PT、APTT현저연장,FIB현저승고,혈소판삼수현저개선(P<0.01혹P<0.05).단량조병사솔비교차이무통계학의의(P>0.05).결론 복방단삼능감소ALI환자PAF적표체,개선ALI환자고응상태화양합,위림상조기치료ALI제공료신방법.
Objective To investigate the effects of compound salvia miitiorrhiza parenteral solution on PAF expression and blood coagulation function in ALI patients.Methods 40 patients of ALI were randomly divided into two groups: control group (20 cases) and treatment group (20 cases).The basic treatments of two groups included primary disease treatment, anti -infection, keeping the balance of water -electrolyte, adrenal corticalhormone treatment and mechanical ventilation.The treatment group was supernumerarily injected with compound salvia miltiorrhiza parenteral solution 20mL and 5% glucose solution injection 250mL for 3d.Serum PAF and thromboxane B_2(TXB_2) level, prothrombin time (PT), activated partial thromboplastin time (APTT), fibrin (Fib), parameter of blood platelets and blood gas analysis were measured before the treatment and 3 days after the treatment.PAF and TXB_2, PT, APTT, parameter of blood platelets and blood gas analysis of two groups were compared before and after the treatment.Results Compared with those before the treatment, the oxygenation were improved, PAF and TXB_2 level decreased, PT and APTT increased, Fib decreased and parameter of blood platelets improved in both groups after the treatment(P <0.01).Compared with control group, the oxygenation were improved, PAF and TXB_2 level decreased, PT and APTT increased, Fib increased and parameter of blood platelets improved in treatment group.however, the mortality between two groupshad no significant difference (P > 0.05).Conclusion Compound salvia miltiorrhiza parenteral solution could decrease the expression of serum PAF in ALI patients.It could also improve coagulation function of ALI and oxygenation.So, it could be a new approach for early clinical treatment of ALI.